North Carolina to ready biopharma production workers; Sanofi grants ops reprieve in R&D shutdown;

> The National Association of Manufacturers will partner with Forsyth Technical Community College in North Carolina to develop a biotech and pharmaceutical production workforce. Article

> Clinical supply operations have been spared in the upcoming closure of Sanofi-Aventis's R&D facility in Great Valley, PA. Report

> The lobby for the generic drug industry, the Generic Pharmaceutical Association, has joined the Partnership for Safe Medicines to fight against counterfeit drugs. Article

> Pfizer finds that one in 100 Israelis buy counterfeit drugs and Viagra is its most widely sold fake. Article

> AAIPharma Services has named Patrick Walsh its chief executive officer. AAIPharma Services release

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)